<DOC>
	<DOCNO>NCT00809770</DOCNO>
	<brief_summary>The purpose study determine effectiveness behavioral treatment , contingency management , reduce stimulant use person serious mental illness .</brief_summary>
	<brief_title>Contingency Management Psychostimulant Abuse Severely Mentally Ill</brief_title>
	<detailed_description>This study evaluate efficacy twelve week contingency management ( CM ) intervention treat psycho-stimulant substance abuse deliver context community mental health center ( CMHC ) set adult suffer serious mental illness ( SMI ) . The CM paradigm use one show effective several recent large clinical trial , use variable magnitude reinforcement procedure . The reinforcer voucher actual item useful day day live population . Two hundred SMI participant co-occurring stimulant disorder recruit large urban CMHC randomize receive either active CM paradigm plus treatment usual ( TAU ) , TAU include delivery reinforcement study involvement ( reinforcement contingent drug abstinence ) . The primary outcome change psycho-stimulant use ( methamphetamine , amphetamine and/or cocaine ) . Secondary outcome include : change use illegal drug alcohol ; change CMHC treatment adherence follow-through ; change psychiatric symptom , quality life , community outcome ( homelessness , incarceration , etc. ) . Additional outcome measure include change drug craving , stage change , nicotine use , HIV risk status . The study involve two phase , 12 week treatment phase , CM control treatment deliver , well 3 month follow phase .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<criteria>Enrolled patient Community Psychiatric Clinic ( CPC ) , large mental health center urban Seattle , Washington ; Between 18 65 year age ; Diagnosis methamphetamine , amphetamine ( illegal ) , cocaine dependence abuse ; CPC medical record diagnosis schizophrenia , schizoaffective disorder , bipolar I II , recurrent major depressive disorder Stimulant drug use one month enrollment ; Ability understand write spoken English ; CPC clinical case manager must affirm potential participant 's ability provide inform consent clinical appropriateness ( i.e. , safety/severity mental/substance/ physical health ) participate study . Any medical/psychiatric condition , severity condition , , opinion Dr. Ries , PI , would compromise safe study participation Chart define organic brain disorder dementia ; Current participation methadone maintenance program ; Any circumstance PI 's opinion precludes safe study participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>stimulant abuse</keyword>
	<keyword>drug abuse</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>bipolar disorder</keyword>
	<keyword>major depressive disorder</keyword>
	<keyword>contingency management</keyword>
	<keyword>psychosocial treatment</keyword>
</DOC>